SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Vasogen-- VAS on TSE -- Ignore unavailable to you. Want to Upgrade?

To: Pluvia who wrote (297)7/26/2005 2:23:52 PM
From: Stephen O  Read Replies (1) | Respond to of 377
 
The FDA is in a state of opprobrium anyway. If a new process produces dramatic results against inflammation, then the FDA will be under intense media pressure and medical community pressure to approve. The FDA could even decide that the only benefit of statin drugs was against inflammation and they come with a whole raft of bad side effects, they could now stop statin drugs and promote Vasogen instead for inflammation.



To: Pluvia who wrote (297)8/2/2005 12:50:20 AM
From: russet  Read Replies (1) | Respond to of 377
 
Who cares about the FDA?,...perhaps investors,... but then there are the rest of us that want effective cures. If efficacy, safety and a longer life is proved, do the rest of us care if the U.S. approves it or not. The drug process will probably be cheaper in Mexico and Canada if the U.S. ignores it.

Good thing Canada pushed through radioisotopes or we'd all be sucking on FDA sour lemons now.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News